OHR-002

Status: Completed

ClinicalTrials.gov Identifier: NCT01678963

OHR-002: Ophthalmic drops (Squalamine Lactate) in patients with wet AMD.

Condition: Neovascular Age-Related Macular Degeneration

Study Type: Interventional

Duration: 29 months

Eligibility:

  • Ages: 50 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.